Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

[Nature of speech disorders in Parkinson disease].

Pawlukowska W, Honczarenko K, Gołąb-Janowska M.

Neurol Neurochir Pol. 2013 May-Jun;47(3):263-70. Review. Polish.

PMID:
23821424
2.

Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment.

Ramig LO, Fox C, Sapir S.

Semin Speech Lang. 2004 May;25(2):169-80. Review.

PMID:
15118943
3.

[Treatment of vocal symptoms in Parkinson's disease: the Lee Silverman method].

Dias AE, Limongi JC.

Arq Neuropsiquiatr. 2003 Mar;61(1):61-6. Epub 2003 Apr 16. Portuguese.

4.

Speech and swallowing disorders in Parkinson disease.

Sapir S, Ramig L, Fox C.

Curr Opin Otolaryngol Head Neck Surg. 2008 Jun;16(3):205-10. doi: 10.1097/MOO.0b013e3282febd3a. Review.

PMID:
18475072
5.

[Intrinsic and co-intrinsic vowel characteristics in cerebellar and parkinsonian dysarthrias].

Baudelle E, Vaissière J, Renard JL, Roubeau B, Chevrie-Müller C.

Folia Phoniatr Logop. 2003 May-Jun;55(3):137-46. French.

PMID:
12771465
6.

Intensive voice treatment in Parkinson's disease: Lee Silverman Voice Treatment.

Sapir S, Ramig LO, Fox CM.

Expert Rev Neurother. 2011 Jun;11(6):815-30. doi: 10.1586/ern.11.43. Review.

PMID:
21651330
7.

Intensive treatment of dysarthria secondary to stroke.

Mahler LA, Ramig LO.

Clin Linguist Phon. 2012 Aug;26(8):681-94. doi: 10.3109/02699206.2012.696173.

PMID:
22774928
8.

Preparing an E-learning-based Speech Therapy (EST) efficacy study: Identifying suitable outcome measures to detect within-subject changes of speech intelligibility in dysarthric speakers.

Beijer LJ, Rietveld AC, Ruiter MB, Geurts AC.

Clin Linguist Phon. 2014 Dec;28(12):927-50. doi: 10.3109/02699206.2014.936627. Epub 2014 Jul 15.

PMID:
25025268
9.

Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.

Sapir S, Spielman JL, Ramig LO, Story BH, Fox C.

J Speech Lang Hear Res. 2007 Aug;50(4):899-912. Erratum in: J Speech Lang Hear Res. 2007 Dec;50(6):1652.

PMID:
17675595
10.

[Parkinsonian dysarthria].

Gentil M, Pollak P, Perret J.

Rev Neurol (Paris). 1995 Feb;151(2):105-12. Review. French.

PMID:
7676137
11.

A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.

Deane KH, Whurr R, Playford ED, Ben-Shlomo Y, Clarke CE.

Cochrane Database Syst Rev. 2001;(2):CD002814. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD002814.

PMID:
11406045
12.

Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease.

Halpern AE, Ramig LO, Matos CE, Petska-Cable JA, Spielman JL, Pogoda JM, Gilley PM, Sapir S, Bennett JK, McFarland DH.

Am J Speech Lang Pathol. 2012 Nov;21(4):354-67. doi: 10.1044/1058-0360(2012/11-0125). Epub 2012 Oct 15.

PMID:
23071195
13.

Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study.

Sapir S, Spielman J, Ramig LO, Hinds SL, Countryman S, Fox C, Story B.

Am J Speech Lang Pathol. 2003 Nov;12(4):387-99.

PMID:
14658991
14.

[Electromyographic study of 4 lip muscles and acoustic findings in parkinsonian dysarthria].

Pellat J, Gentil M, Chevalier C, Vila A, Pollak P, Perret J.

Rev Neurol (Paris). 1983;139(3):205-13. French.

PMID:
6612135
15.

Acoustic and intelligibility characteristics of sentence production in neurogenic speech disorders.

Weismer G, Jeng JY, Laures JS, Kent RD, Kent JF.

Folia Phoniatr Logop. 2001 Jan-Feb;53(1):1-18.

PMID:
11125256
16.

Effect of speech task on intelligibility in dysarthria: a case study of Parkinson's disease.

Kempler D, Van Lancker D.

Brain Lang. 2002 Mar;80(3):449-64.

PMID:
11896652
17.

[Speech and voice disorders in Parkinson's disease].

Martnez-Sánchez F.

Rev Neurol. 2010 Nov 1;51(9):542-50. Review. Spanish.

PMID:
20979034
18.

Acoustic investigation of stress patterns in Parkinson's disease.

Tykalova T, Rusz J, Cmejla R, Ruzickova H, Ruzicka E.

J Voice. 2014 Jan;28(1):129.e1-129.e8. doi: 10.1016/j.jvoice.2013.07.001. Epub 2013 Oct 2.

PMID:
24094802
19.

Acoustic analysis of speech timing in Huntington's disease.

Hertrich I, Ackermann H.

Brain Lang. 1994 Aug;47(2):182-96.

PMID:
7953613
20.

Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.

Herd CP, Tomlinson CL, Deane KH, Brady MC, Smith CH, Sackley CM, Clarke CE.

Cochrane Database Syst Rev. 2012 Aug 15;8:CD002814. doi: 10.1002/14651858.CD002814.pub2. Review.

PMID:
22895931
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk